Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature

1 Jun 2021

Abstract excerpt

Numerous prognostic signatures to bladder cancer (BCa) have been reported, but many of them limited to either nonmuscle-invasive (NMIBC) or muscle-invasive BCa (MIBC), and inherent technical biases across platforms impeded clinical application. As cancer immunity plays a critical role in tumor progression,1 we collected 1235 BCa patients from nine independent cohorts across different platforms (Tables S1 and S2)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34185409
DOI: 10.1002/ctm2.453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signaturePMID 34185409Read ↗

Integrated Analysis Identifies and Validates a Novel Signature Based on Immune Related Gene Predicting Survival in Bladder Urothelial CarcinomaSemantic proximity Read ↗

Identification of subgroups of bladder cancer based on immune gene signatureSemantic proximity Read ↗

Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity Read ↗

The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity Read ↗

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancerSemantic proximity Read ↗

Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA databaseSemantic proximity Read ↗

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)Semantic proximity Read ↗

New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity Read ↗

Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity Read ↗

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune LandscapesSemantic proximity Read ↗

Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevanceSemantic proximity Read ↗

Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.